MENU
+Compare
TRUMY
Stock ticker: OTC
AS OF
Nov 18 closing price
Price
$14.96
Change
-$0.32 (-2.09%)
Capitalization
22.33B

TRUMY Terumo Corp. Forecast, Technical & Fundamental Analysis

Started as a clinical thermometer producer in Japan in 1921, Terumo is a comprehensive medical device player with a diversified global revenue... Show more

TRUMY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for TRUMY with price predictions
Nov 18, 2025

TRUMY sees MACD Histogram crosses below signal line

TRUMY saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 12, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 42 instances where the indicator turned negative. In of the 42 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 29, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on TRUMY as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TRUMY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for TRUMY's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TRUMY advanced for three days, in of 300 cases, the price rose further within the following month. The odds of a continued upward trend are .

TRUMY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 211 cases where TRUMY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.384) is normal, around the industry mean (9.047). P/E Ratio (26.122) is within average values for comparable stocks, (152.239). Projected Growth (PEG Ratio) (2.173) is also within normal values, averaging (2.537). Dividend Yield (0.006) settles around the average of (0.017) among similar stocks. P/S Ratio (3.228) is also within normal values, averaging (111.346).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. TRUMY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TRUMY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
TRUMY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

TRUMY is expected to report earnings to rise 11.62% to 17 cents per share on February 05

Terumo Corp. TRUMY Stock Earnings Reports
Q4'25
Est.
$0.17
Q3'25
Missed
by $0.01
Q2'25
Beat
by $0.02
Q1'25
Missed
by $0.05
Q4'24
Missed
by $0.01
The last earnings report on November 12 showed earnings per share of 15 cents, missing the estimate of 16 cents. With 329.41K shares outstanding, the current market capitalization sits at 22.33B.
A.I.Advisor
published Dividends

TRUMY paid dividends on July 12, 2024

Terumo Corp. TRUMY Stock Dividends
А dividend of $0.14 per share was paid with a record date of July 12, 2024, and an ex-dividend date of March 27, 2024. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
2-44-1 Hatagaya
Phone
+81 333748111
Employees
26482
Web
https://www.terumo.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XPH52.140.75
+1.46%
State Street® SPDR® S&P® PhrmctlsETF
SLV46.100.63
+1.39%
iShares Silver Trust
DIVP24.710.12
+0.49%
Cullen Enhanced Equity Income ETF
DBA26.40-0.03
-0.11%
Invesco DB Agriculture
NVDG18.25-1.11
-5.73%
Leverage Shares 2X Long Nvda Daily ETF

TRUMY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TRUMY has been loosely correlated with HOCPY. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TRUMY jumps, then HOCPY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRUMY
1D Price
Change %
TRUMY100%
-2.09%
HOCPY - TRUMY
51%
Loosely correlated
-2.41%
SSMXY - TRUMY
45%
Loosely correlated
-0.31%
SMTI - TRUMY
43%
Loosely correlated
-0.52%
OLYMY - TRUMY
40%
Loosely correlated
-1.14%
AZTA - TRUMY
39%
Loosely correlated
+0.20%
More

Groups containing TRUMY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRUMY
1D Price
Change %
TRUMY100%
-2.09%
Pharmaceuticals: Other
industry (103 stocks)
20%
Poorly correlated
+0.16%
Pharmaceuticals
industry (378 stocks)
19%
Poorly correlated
-0.03%